The content on this site is intended for healthcare professionals only
Dr Avan Armaghani, speaks to ecancer at the Best of ASCO®️ 2024 Miami Symposium and discusses her presentation on updates on triple negative breast cancer and the role of immunotherapy in cancer.
She discusses the groundbreaking impact on immunotherapy in breast cancer.
Dr Armaghani goes on to discuss what is next for triple negative breast cancer.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Multiple Myeloma: evolving paradigm - Panel Discussion
Choosing Wisely in endometrial & cervix cancers: Medical therapy
Biomarkers, predictive and prognostic factors of resistance to immunotherapy
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Uncommon genetic aberrations NTRK, RET, NRG
Relapsed refractory multiple myeloma
Multiple myeloma (A cancer arising from plasma cells)
OncoAlert Round Up for August 25th - 31st, 2023
